We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Shows Promise for Genetic Form of ALS in Early Stage Trial

News   May 02, 2019 | Original story from American Academy of Neurology

 
Drug Shows Promise for Genetic Form of ALS in Early Stage Trial
 
 
 

RELATED ARTICLES

Children of Both Young and Old Parents Are at Risk of Neurodevelopmental Disorders

News

A new study reports that parental age is linked to the risk for the development of neuropsychiatric disorders in children, including autism spectrum disorder; attention-deficit/hyperactivity disorder; obsessive-compulsive disorder; and Tourette's disorder/chronic tic disorder.

READ MORE

A Roadmap of Cell Death in the Alzheimer's Brain

News

Scientists have identified a new mechanism that accelerates aging in the brain and gives rise to the most devastating biological features of Alzheimer's disease.

READ MORE

Testing Personalized Treatments in 5 days With 3D

News

Researchers have developed a cell co-culture platform that can reproduce a patient’s tumor in 3D and test the best treatment combinations for its specific case in just five days.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE